Punicagranatum as a local drug delivery system: A Clinico microbiological study
The use of herbal/ natural compounds can be comparatively safer alternative to those of synthetic compounds for periodontal therapy. The present study aims to investigate the effect of pomegranate extracts in form of chip for treating adult patients affected with periodontitis followed with scaling and root planing. The study was conducted in two parts: Invitro and Invivo. The study was a randomized controlled study and was addressed by clinical and microbiological parameters at base line and subsequent intervals.
Material and methods:In vitro release was performed by using Keshary-chien diffusion cell for randomly selected strip. In vivo30patients with adult periodontitis having initial pocket depth ≥4 mm were enrolled into this research. For each subject two experimental sites were chosen located in symmetrical quadrants. Sites were randomly assigned to control group or test group. Then subgingival application of medicated chips was done in both groups. The clinical parameters were recorded at baseline, 30 days and 90 days. Descriptive statistical analysis has been carried out in present study.
Results: The in vivo study confirmed significant improvements of plaque index ratings with significant reduction in gingival index, plaque index and relative attachment level scores at 90 days as compared to control group. While Porphyromonasgingivalis ,Prevotellaintermedia , Fusobacteriumintermedia and Aggregatibacteractinomycetemcomitans showed a more significant reduction at 90 days as compared to control group. In vitro results showed complete drug release in – 72- 80 hours .Matrix degrades between 3 to 4 days. Pomegranate extracts in chip may provide additional advantages to scaling and root planing for improving periodontal status.
KEYWORDS: Chip, gingiva, periodontal, pomegranate, punicagranatum
 H.F. Jenkinson and R.J.lamont.oral microbial communities in sickness and in health, Trends in microbiology, 2005,13:(12):
 AlexandreDaherYunes Salgado, Juliana Lemos MAIA1, SérgioLuís da Silva Pereira,et al. Antiplaque and antigingivitis effects of a gel containing punicagranatumlinnextract.a double-blind clinical study in humans J appl oral sci.2006;14(3):162-6
 Themal de B. Machado, Ivana C.R. Leal,Ana Claudia F. Amaral et al. Antimicrobial Ellagitannin of Punicagranatum Fruits. J.Braz. chem. Soc., 2002:13(5):606-610
 Turesky S ,Gilmore ND , Glickman I . Reduced plaque formation by the chloromethyl analogue of Vitamin C.J Periodontol 1970;41:41.
 Loe H .The gingival index , the plaque index and the retention index systems. J Periodontol1967 ; 38 : 610
 VasudhaPai, ThangjamRubeeChanu, RituparnaChakraborty et al. Evaluation of the antimicrobial activity of Punicagranatum peel against the enteric pathogens: An invitro study. Asian Journal of Plant Science and Research, 2011, 1 (2):57-62.
 Sh. Abdollahzadeh, RY. Mashouf, H. Mortazavi et al. Antibacterail and anti fungal activities of pinicagranatum peel extracts against oral pathogens.2001:8:1-6.
 Noguchi T. Fukuda M. Ishikawa I. Periodontal treatment by local drug delivery using resorbable base material. Adv Dent Res 1988;2:40l-404.
 Manoj kumar, G.L. Prabhushankar and P.R. Satheshbabu. Formulation and in vitro evaluation of film containing metronidazole. 2010:2(4):2188-2193.
 Roxanne A. Lowenguth and Gary Greenstien.Clinical and microbiological response to nonsurgical mechanical therapy. Periodontal 2000.9:14-22
 Roul G Caffesse, Luis F. Mota and Edith C Morrison. The rationale for periodontal therapy. Periodontal 2000.1995:9:7-13
 MeenakshiShukla, KalpanaGupta,ZafarRasheed et al. Bioavailable constituents/metabolites of pomegranate preferential inhibit COX2 activity ex vivo and IL-1 beta- induced PGE2 production in human chondrocyte in vitro. J. Inflammation 2008,5:9
 SaadsabbarDahham, Mir Naiman Ali, Hajeratabassum et al. Studies on antibacterial and antifungal activity of pomegranate (Punicagranatum L.) J. Agric. And Environ. Sci.2010:9(3):273-281.